Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.

[1]  S. Bloom,et al.  Incretins and other peptides in the treatment of diabetes , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[2]  M. Bessler,et al.  Differential Effects of Gastric Bypass and Banding on Circulating Gut Hormone and Leptin Levels , 2006, Obesity.

[3]  P. Butler,et al.  Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. , 2006, Diabetes care.

[4]  A. Mari,et al.  Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery , 2006, Diabetes.

[5]  Josep Vidal,et al.  Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. , 2006, The Journal of clinical endocrinology and metabolism.

[6]  P. Butler,et al.  Comment to: Patti ME, Mcmahon G, Mun EC et al. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236–2240 , 2006, Diabetologia.

[7]  R. Batterham,et al.  Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters , 2006, Annals of surgery.

[8]  J. Holst,et al.  Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia , 2005, Diabetologia.

[9]  D. Cummings.  Gastric bypass and nesidioblastosis--too much of a good thing for islets? , 2005, The New England journal of medicine.

[10]  R. Lloyd,et al.  Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. , 2005, The New England journal of medicine.

[11]  S. Aylwin.  Gastrointestinal surgery and gut hormones , 2005 .

[12]  S. Woods,et al.  Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. , 2005, American journal of physiology. Endocrinology and metabolism.

[13]  M. Nauck,et al.  GIP as a potential therapeutic agent? , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[14]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[15]  D. Cummings,et al.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.

[16]  Yuichiro Yamada,et al.  Inhibition of gastric inhibitory polypeptide signaling prevents obesity , 2002, Nature Medicine.

[17]  D. Drucker,et al.  Minireview: the glucagon-like peptides. , 2001, Endocrinology.

[18]  J. Holst,et al.  Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans , 1994, Diabetes.

[19]  J. Holst,et al.  Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy , 1991, Digestive Diseases and Sciences.

[20]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[21]  J. Polak,et al.  The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats , 1984, Physiology & Behavior.

[22]  J. Holst,et al.  Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. , 1983, The Journal of clinical endocrinology and metabolism.

[23]  J. Holst.  Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. , 1982, The Biochemical journal.

[24]  M. Bessler,et al.  Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. , 2005, The Journal of clinical endocrinology and metabolism.

[25]  A. Andersen,et al.  Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. , 1979, Scandinavian journal of gastroenterology.